Effectiveness of Iranian Medicine Product: Tamarrindus Indica L. Syrup (Somalax) on Patients with Acne.
Phase 3
Recruiting
- Conditions
- Acne.Acne, unspecifiedL70.9
- Registration Number
- IRCT20191103045318N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Age over 18 years
Mild to moderate acne on the face
Lack of a history of systemic disease when the patient has to take systemic medication
No use of inducing or reducing acne medications in the last 2 weeks
No facial surgery in the last month
No pregnancy and no breast feeding
Willingness to participate in the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acne severity index. Timepoint: At baseline (before intervention) and at 6, 12, and 16 weeks after drug administration. Method of measurement: The lesion is counted by the researcher and placed in the ASI formula.
- Secondary Outcome Measures
Name Time Method Quality of life score. Timepoint: At baseline (before intervention) and 16 weeks after drug administration. Method of measurement: DLQI Quality of Life Questionnaire.